Report ID: SQMIG35A2534
Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Medical Device Contract Manufacturing Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Medical Device Contract Manufacturing industry players.
The Global Medical Device Contract Manufacturing Market is significantly driven by the growing complexity of medical technologies combined with increasingly stringent regulatory standards worldwide. As devices evolve toward miniaturized, digitally connected, and highly precise systems, original equipment manufacturers face escalating production challenges, higher compliance costs, and greater risks of regulatory delays. This leads many companies to outsource to contract manufacturers with advanced engineering expertise, specialized equipment, validated manufacturing processes, and robust quality certifications. Consequently, outsourcing enables faster development cycles, improved reliability, assured compliance with FDA and international standards, reduced operational burdens, and quicker time-to-market for innovative medical devices.
According to SkyQuest Technology “Global Medical Device Contract Manufacturing Market” By Product Class (Class I, Class II), By Service Type (Device Development & Manufacturing, Quality Management), By Therapeutic Area, By Region - Industry Forecast 2026-2033,” Global medical device contract manufacturing market is projected to grow at a CAGR of over 11.4% by 2033, on account of urgent need for automating quantified data. A crucial factor influencing the Global Medical Device Contract Manufacturing Market is the growing emphasis on cost efficiency among medical device companies. As competition intensifies and healthcare providers demand affordable yet high-quality devices, OEMs seek ways to minimize capital expenditure, reduce production complexity, and stabilize profit margins.
|
Company |
Est. Year |
Headquarters |
Revenue |
Key Services |
|
Jabil Inc. |
1966 |
St. Petersburg, Florida |
USD 28.9 billion (2024) |
Design engineering, precision molding, electronics manufacturing, device assembly, supply chain management, packaging |
|
Flex Ltd. |
1969 |
Austin, Texas |
USD 26.415 billion (2024) |
Product design, engineering, electronics manufacturing, medical device assembly, testing and validation, supply chain services |
|
Celestica Inc. |
1994 |
Toronto, Ontario |
USD 9.646 billion (2024) |
Design and engineering, precision manufacturing, electronics integration, medical device assembly, quality testing, regulatory compliance support |
|
Sanmina Corporation |
1980 |
San Jose, California |
USD 7.57 billion (2024) |
Design and development, electronics manufacturing, mechanical system assembly, PCB manufacturing, testing and validation, logistics and supply chain services |
|
Integer Holdings Corporation |
1970 |
Plano, Texas |
NA |
Medical device design, component manufacturing, finished device assembly, sterilization management, testing services, outsourcing manufacturing solutions |
|
Plexus Corp. |
1979 |
Neenah, Wisconsin |
USD 3.96 billion (2024) |
Product development, engineering design, electronics manufacturing, device assembly, quality assurance, regulatory compliance support, supply chain management |
|
Thermo Fisher Scientific Inc. |
2006 |
Waltham, Massachusetts |
USD 42.88 billion (2024) |
Pharmaceutical and medical device manufacturing, injection molding, precision machining, sterile manufacturing, packaging solutions, validation and quality services |
|
Phillips-Medisize |
1964 |
Hudson, Wisconsin |
USD 4 billion (2024) |
Design and engineering, drug delivery device manufacturing, plastics molding, electronics integration, assembly and packaging, human factors engineering, regulatory support |
|
Viant Medical |
1968 |
Foxborough, Massachusetts |
USD 1.2 billion (2024) |
Design and development, precision molding, medical component manufacturing, device assembly, packaging and labeling, sterilization management, supply chain services |
|
West Pharmaceutical Services, Inc. |
1923 |
Exton, Pennsylvania |
USD 2.893 billion (2024) |
Drug delivery system manufacturing, component molding, containment solutions, device assembly, packaging, analytical testing, regulatory and technical support |
Jabil Inc. is a leading global medical device contract manufacturing partner, supporting healthcare companies with advanced design, engineering, and large-scale production capabilities. Founded in 1966 and headquartered in Florida, the company has built a strong global footprint with state-of-the-art facilities specializing in precision molding, electronics integration, digital health solutions, diagnostics, and minimally invasive device manufacturing. Jabil emphasizes regulatory compliance, quality excellence, and accelerated time-to-market, helping OEMs reduce risk and cost while enhancing product innovation. The company continues to expand its healthcare manufacturing platforms to meet rising demand for complex, high-performance medical technologies worldwide.
Flex Ltd. is a prominent global player in the medical device contract manufacturing market, delivering comprehensive design, engineering, and large-scale production solutions to leading healthcare companies. Established in 1969, the company leverages its strong global manufacturing network and advanced technological capabilities to support complex medical devices, diagnostics equipment, wearable healthcare solutions, and minimally invasive technologies. Flex emphasizes quality, precision, and regulatory compliance across its operations, ensuring reliable manufacturing outcomes. With its focus on innovation, digital integration, and efficient supply chain execution, Flex continues to strengthen its role as a trusted partner in advancing modern medical technologies worldwide.
Celestica Inc. is a significant global participant in the medical device contract manufacturing market, providing end-to-end design, engineering, and precision manufacturing solutions to leading healthcare companies. Founded in 1994 and headquartered in Toronto, the company leverages advanced production capabilities, electronics integration expertise, and rigorous quality systems to support complex medical devices, diagnostic systems, and healthcare technology platforms. Celestica emphasizes reliability, regulatory compliance, and accelerated product commercialization, helping OEMs reduce development risk and operational costs. With its expanding global footprint and technology-driven manufacturing approach, the company continues to strengthen its role in advancing innovative, high-performance medical devices worldwide.
Sanmina Corporation is a key global player in the medical device contract manufacturing market, offering comprehensive design, engineering, precision manufacturing, and assembly solutions for leading healthcare companies worldwide. Founded in 1980 and headquartered in California, the company supports the production of complex medical equipment, diagnostic systems, life-sustaining devices, and advanced electronic healthcare technologies. Sanmina emphasizes stringent quality control, regulatory compliance, and reliability across its global facilities, helping OEMs reduce development challenges, optimize costs, and accelerate product launches. With strong technological expertise and integrated supply chain capabilities, Sanmina continues to enhance its position as a trusted partner in modern medical manufacturing.
Integer Holdings Corporation is a leading global medical device contract manufacturing partner, recognized for its specialized expertise in developing and producing high-precision medical technologies. Founded in 1970 and headquartered in Texas, the company supports a wide range of healthcare segments including cardiac rhythm management, neuromodulation, vascular, orthopedics, and advanced surgical solutions. Integer offers comprehensive capabilities spanning design, engineering, component manufacturing, finished device assembly, testing, and sterilization support. With a strong focus on quality, regulatory compliance, innovation, and operational excellence, the company helps medical device OEMs reduce risk, enhance performance, and bring advanced, life-improving technologies to market efficiently worldwide.
Plexus Corp. is a prominent global medical device contract manufacturing partner, specializing in the design, engineering, and large-scale production of complex healthcare technologies. Founded in 1979 and headquartered in Wisconsin, the company supports leading medical OEMs with capabilities spanning product development, electronics manufacturing, precision assembly, testing, and regulatory compliance. Plexus focuses on high-reliability medical systems, diagnostics, life-sustaining equipment, and advanced therapeutic devices. By combining strong technical expertise, disciplined quality systems, and global manufacturing infrastructure, the company helps customers reduce development risks, accelerate time-to-market, and deliver safe, high-performance medical technologies to healthcare providers and patients worldwide.
Thermo Fisher Scientific Inc. is a major global contributor to the medical device contract manufacturing market, leveraging its strong scientific expertise and advanced production infrastructure to support leading healthcare innovators. Formed in 2006 and headquartered in Massachusetts, the company provides comprehensive manufacturing solutions including precision molding, sterile manufacturing, diagnostics production, components development, packaging, and validation services. With its robust quality systems, regulatory excellence, and technological innovation, Thermo Fisher helps OEMs enhance product reliability, streamline manufacturing, and accelerate commercialization. Its expanding healthcare manufacturing capabilities continue to support the growing demand for high-quality, safe, and technologically advanced medical devices worldwide.
Phillips-Medisize is a globally recognized leader in the medical device contract manufacturing market, specializing in the design, development, and production of high-precision drug delivery systems, diagnostic devices, and connected healthcare solutions. Founded in 1964 and headquartered in Wisconsin, the company integrates advanced engineering, human-factors design, plastics molding, electronics integration, and large-scale manufacturing to support complex healthcare innovations. Phillips-Medisize emphasizes strict regulatory compliance, quality excellence, and reliable product performance, helping OEMs reduce risk, accelerate product launches, and enhance patient outcomes. With expanding global facilities and strong technology capabilities, the company continues to advance sophisticated, patient-centric medical devices worldwide.
Viant Medical is a prominent global player in the medical device contract manufacturing market, known for its comprehensive capabilities in designing, engineering, and producing high-quality medical technologies. Founded in 1968 and headquartered in Massachusetts, the company supports a wide range of healthcare applications including surgical devices, drug delivery systems, diagnostics, and minimally invasive technologies. Viant offers precision molding, advanced materials expertise, assembly, packaging, and sterilization management, backed by strong regulatory and quality systems. With its global manufacturing footprint and innovation-focused approach, the company helps OEMs enhance efficiency, reliability, and time-to-market for critical medical devices worldwide.
West Pharmaceutical Services, Inc. is a leading global partner in the medical device and pharmaceutical delivery contract manufacturing market, renowned for its expertise in containment and drug delivery solutions. Founded in 1923 and headquartered in Pennsylvania, the company specializes in developing and manufacturing components and systems for injectable medicines, including elastomer components, delivery devices, and containment solutions that ensure drug safety, integrity, and precision. With strong regulatory compliance, advanced engineering capabilities, and high-quality manufacturing standards, West supports pharmaceutical and medical device companies in enhancing reliability, improving patient safety, and efficiently bringing critical healthcare solutions to market worldwide.
The global medical device contract manufacturing market is poised for sustained expansion as medical technologies become more sophisticated and healthcare systems increasingly demand cost-efficient, high-quality solutions. The combination of technological advancement, regulatory pressure, and the need for rapid commercialization is pushing OEMs to rely heavily on specialized manufacturing partners. With strong capabilities in engineering excellence, quality assurance, large-scale production, and compliance management, contract manufacturers are evolving into strategic innovation partners rather than simple production units. As demand for advanced diagnostics, minimally invasive devices, and digital health solutions rises, contract manufacturing will continue to play a critical role in shaping the future of global healthcare delivery.
REQUEST FOR SAMPLE
Class II (moderate complexity) devices, such as surgical gloves, diagnostic imaging, and infusion pumps are most commonly contracted out to contract manufacturers because they cover moderate levels of regulatory complexity and are applied in a wide variety of high-demand therapeutic areas.
The main drivers include the increased demand for medical devices, more OEMs outsourcing to reduce costs, searching for innovation, and the introduction of technology such as 3D Printing and automation.
Regulatory compliance creates challenges due to differences in worldwide standards. Manufacturers must adhere to both the FDA, EMA, and a multitude of other regulatory bodies, therefore it is essential to find partners who have experience in and understand compliance.
Although the economy has slowed, the medical device contract manufacturing market has managed to withstand the economic fluctuations. Increased outsourcing from OEMs and consistent demand for medical devices (including ventilators and high-demand IVD products) led to a significant share of the medical device market being added even during a recession in years like 2020.
The challenges facing the industry are of major concern given the complex regulatory requirements, which are coupled with supply chain disruptions globally, making production difficult, costly, and challenging for new devices to enter the market.
Global Medical Device Contract Manufacturing Market size was valued at USD 70.83 Billion in 2024 and is poised to grow from USD 78.9 Billion in 2025 to USD 187.15 Billion by 2033, growing at a CAGR of 11.4% during the forecast period (2026–2033).
Thermo Fisher Scientific Inc. (United States), Jabil Inc. (United States), Flex Ltd. (United States), Plexus Corp. (United States), Sanmina Corporation (United States), Integer Holdings Corporation (United States), TE Connectivity Ltd. (Switzerland), Nipro Corporation (Japan), Onex Corporation (Celestica Inc.) (Canada), West Pharmaceutical Services, Inc. (United States), Benchmark Electronics Inc. (United States), EQT Group (Recipharm AB) (Sweden), Gerresheimer AG (Germany), Kimball Electronics, Inc. (United States), Nortech Systems Incorporated (United States), Carclo plc (United Kingdom), Nolato GW, Inc. (Sweden), Viant Medical Holdings, Inc. (United States), Tecomet, Inc. (United States), SMC Corporation (United States)
The key driver of the medical device contract manufacturing market is the increasing demand for cost-efficient production, allowing healthcare companies to outsource manufacturing, focus on innovation, reduce time-to-market, and meet the growing global demand for advanced medical devices.
A key market trend in the medical device contract manufacturing market is the adoption of advanced manufacturing technologies like automation, additive manufacturing (3D printing), and digitalization to improve precision, reduce costs, and accelerate product development cycles.
North America accounted for the largest share in the medical device contract manufacturing market, driven by a well-established healthcare infrastructure, high demand for innovative medical devices, strong regulatory support, and the presence of major medical device manufacturers and contract service providers.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2534
sales@skyquestt.com
USA +1 351-333-4748